Melissa Pilewskie, MD

In this insightful discussion, Dr. Melissa Pilewskie and Dr. Stephanie Downs-Canner delve into the complexities of managing ductal carcinoma in situ (DCIS). They tackle crucial topics like the balance between over-treatment and preventing invasive cancer. With new data from the COMET trial, they explore personalized treatment strategies and the importance of active surveillance. The conversation also highlights risk assessment tools, the impact of radiation, and patient preferences, emphasizing the need for tailored approaches in breast surgical oncology.